Compounds > 1-acetyl-3,2-toluyl-5-fluorouracil
Page last updated: 2024-09-03

1-acetyl-3,2-toluyl-5-fluorouracil and Thrombopenia

1-acetyl-3,2-toluyl-5-fluorouracil has been researched along with Thrombopenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, FY; Han, J; Li, L; Li, Q; Sui, GJ; Wang, PH; Zhang, Y; Zhang, YC; Zhang, ZH; Zhou, MZ; Zhu, YG1

Trials

1 trial(s) available for 1-acetyl-3,2-toluyl-5-fluorouracil and Thrombopenia

ArticleYear
[Phase III clinical study of a new anticancer drug atofluding].
    Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:12

    Topics: Adult; Aged; Anemia; Antineoplastic Agents; Female; Fluorouracil; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia; Treatment Outcome

2002